These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29524476)

  • 21. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.
    Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M
    Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
    Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
    Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-site atrial pacing for atrial fibrillation in patients without bradycardia.
    Lau CP; Tse HF; Yu CM; Teo WS; Kam R; Ng KS; Huang SS; Lin JL; Fitts SM; Hettrick DA; Hill MR;
    Am J Cardiol; 2001 Aug; 88(4):371-5. PubMed ID: 11545756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
    Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
    Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of the Atrial Electromechanical Delay in Predicting Atrial Fibrillation in Myotonic Dystrophy Type 1 Patients.
    Russo V; Rago A; Ciardiello C; Russo MG; Calabrò P; Politano L; Nigro G
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):65-72. PubMed ID: 26331589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
    Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E;
    Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia.
    Padeletti L; Pürerfellner H; Adler SW; Waller TJ; Harvey M; Horvitz L; Holbrook R; Kempen K; Mugglin A; Hettrick DA;
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1189-95. PubMed ID: 14678133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators.
    Sweeney MO; Shea JB; Fox V; Adler S; Nelson L; Mullen TJ; Belk P; Casavant D; Sheldon T
    Heart Rhythm; 2004 Jul; 1(2):160-7. PubMed ID: 15851147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT).
    Carlson MD; Ip J; Messenger J; Beau S; Kalbfleisch S; Gervais P; Cameron DA; Duran A; Val-Mejias J; Mackall J; Gold M;
    J Am Coll Cardiol; 2003 Aug; 42(4):627-33. PubMed ID: 12932592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.
    Boriani G; Manolis AS; Tukkie R; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; Gulizia M; Samoilenko IV; Wolff C; Holbrook R; Gavazza F; Padeletti L;
    Heart Rhythm; 2015 Jun; 12(6):1192-200. PubMed ID: 25701774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
    Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
    Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias.
    Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L;
    Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study.
    Lazarus A; Varin J; Babuty D; Anselme F; Coste J; Duboc D
    J Am Coll Cardiol; 2002 Nov; 40(9):1645-52. PubMed ID: 12427418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial.
    Gold MR; Adler S; Fauchier L; Haffajee C; Ip J; Kainz W; Kawasaki R; Prakash A; Táborský M; Waller T; Wilson V; Li S; Hoffmann E;
    Heart Rhythm; 2009 Mar; 6(3):295-301. PubMed ID: 19251200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs.
    Sweeney MO; Ellenbogen KA; Casavant D; Betzold R; Sheldon T; Tang F; Mueller M; Lingle J;
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):811-7. PubMed ID: 16101620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient.
    Russo V; Rago A; DI Meo F; Cioppa ND; Papa AA; Russo MG; Nigro G
    Acta Myol; 2014 Dec; 33(3):149-51. PubMed ID: 25873784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study.
    Botto GL; Ricci RP; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Garutti C; Vainer L; Kozák M;
    Heart Rhythm; 2014 Jun; 11(6):992-1000. PubMed ID: 24418164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing.
    Saksena S; Prakash A; Hill M; Krol RB; Munsif AN; Mathew PP; Mehra R
    J Am Coll Cardiol; 1996 Sep; 28(3):687-94. PubMed ID: 8772757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
    Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
    Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
    Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
    J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.